• All Share : 48515.1341
    DOWN -2.92%
    Top40 - (Tradeable) : 42979.7709
    DOWN -3.09%
    Financial 15 : 15827.5998
    DOWN -3.19%
    Industrial 25 : 62445.3481
    DOWN -2.72%
    Resource 10 : 34164.5481
    DOWN -4.66%

  • ZAR/USD : 13.3963
    DOWN -0.22%
    ZAR/GBP : 20.4829
    DOWN -0.13%
    ZAR/EUR : 15.1185
    DOWN -0.47%
    ZAR/JPY : 0.1111
    DOWN -0.80%
    ZAR/AUD : 9.4073
    DOWN -0.09%

  • Gold US$/oz : 1139.9
    UNCHANGED0.00%
    Platinum US$/oz : 1003.1
    UNCHANGED0.00%
    Silver US$/oz : 14.61
    UNCHANGED0.00%
    Palladium US$/oz : 573
    UNCHANGED0.00%
    Brent Crude : 48.62
    UNCHANGED0.00%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Send Mail

Melanoma drug nearly doubles survival time: study

A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said.

AFP Relaxnews

 24 February, 2012 10:45
* Required